Inactivation of both FHIT and TP53 genes is frequently observed in primary non-small cell lung cancers (NSCLC) and cell lines and may contribute to resistance to apoptotic stimuli elicited by various anti-tumor drugs [42]. The gene discussed is FHIT; the disease is non-small cell lung carcinoma.